Published in Obesity and Diabetes Week, May 10th, 2004
While companies such as InnoMed Technologies, who recently developed a facial interface to provide comfort to millions of people suffering from sleep apnea, aid in patient compliance, pharmaceutical companies are also making strides to decrease noncompliance. For example, Roche established...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week